Search results
Results from the WOW.Com Content Network
In 2017, Optum accounted for 44 percent of UnitedHealth Group's profits. [3] In 2019, Optum's revenues surpassed $100 billion for the first time, growing by 11.1% year over year, making it UnitedHealth’s fastest-growing unit at the time. [4] [5]
In 2017, UnitedHealth's Optum unit acquired Rally Health, [46] a company started by Audax Health's executives. [47] Prior to acquisition, in 2015, UnitedHealth supported Rally Health as a majority investor, [ 48 ] and through enrolling 5 million UnitedHealth policy holders in Rally Health's flagship product, RallySM.
Catamaran Corporation (formerly SXC Health Solutions) is the former name of a company that now operates within UnitedHealth Group's OptumRX division (since July 2015). It sells pharmacy benefit management and medical record keeping services to businesses in the United States [3] and to a broad client portfolio, including health plans and employers. [4]
In January 2015, the company bought MWI Veterinary for $2.5 billion. In October, [16] they agreed to buy PharMEDium, a compounding drug company, for $2.58 billion. [16] On January 3, 2018, AmerisourceBergen acquired H. D. Smith, the largest privately-held national pharmaceutical wholesaler in the U.S. [17] [18]
Medco Health Solutions, Inc. was an American Pharmacy Benefits Management (PBM) company. Medco provided pharmacy services to private and public employers, health plans, labor unions, government agencies, and individuals served by Medicare Part D Prescription Drug Plans.
ExpressScripts and Optum were not immediately available for comment. Pharmacy benefit managers came under a House Oversight Committee investigation for their influence over prescription drug prices.
In March 2024, Ben was diagnosed with leukemia and lymphoma, undergoing surgery in July. [7] He died on November 7, 2024, at age 10. [7] Following Ben's passing, Ben's younger brother Peter started to travel with Herbstreit and began appearing on Thursday Night Football and College GameDay.
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...